Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2229640 | 1.00 | ALDH1A1 (0.39) | ALDH1A1EPHX2TBXAS1MEN1KMT2A | |
| SCHEMBL4359174 | 0.93 | THRB (0.40) | ALDH1A1EPHX2TBXAS1SMN1; SMN2TSHR | |
| SCHEMBL8928146 | 0.93 | ALDH1A1 (0.50) | ALDH1A1EPHX2TBXAS1MEN1KMT2A | |
| SCHEMBL3800714 | 0.88 | ALDH1A1 (0.38) | ALDH1A1TBXAS1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2230978 | 0.88 | ALDH1A1 (0.38) | ALDH1A1TBXAS1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL156151 | 0.88 | ALDH1A1 (0.50) | ALDH1A1TBXAS1MEN1KMT2ATSHR | |
| SCHEMBL11126565 | 0.88 | TSHR (0.39) | ALDH1A1TBXAS1TSHRTET2 | |
| SCHEMBL13685002 | 0.87 | ALDH1A1 (0.52) | ALDH1A1EPHX2TBXAS1MEN1KMT2A | |
| SCHEMBL13684994 | 0.87 | ALDH1A1 (0.52) | ALDH1A1EPHX2TBXAS1MEN1KMT2A | |
| SCHEMBL5569902 | 0.85 | ALDH1A1 (0.41) | ALDH1A1EPHX2MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-3934705-B1 | INTRAOCULAR LENS COMPOSITIONS | TELEON HOLDING B V (NL) | 2025-11-19 | — | — | EP | claimed |
| EP-3787509-B1 | IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | HOFFMANN LA ROCHE (CH) | 2022-06-22 | — | — | EP | claimed |
| US-20210138218-A1 | ULTRASOUND-RESPONSIVE CONTAINERS FOR DRUG DELIVERY | BIONAUT LABS LTD. (IL) | 2021-05-13 | — | — | US | claimed |
| EP-3787595-A1 | ULTRASOUND-RESPONSIVE CONTAINERS FOR DRUG DELIVERY | Bionaut Labs Ltd. (IL) | 2021-03-10 | — | — | EP | claimed |
| EP-3787509-A1 | IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | F. Hoffmann-La Roche AG (CH) | 2021-03-10 | — | — | EP | claimed |
| US-20210045664-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE, INC. | 2021-02-18 | — | — | US | claimed |
| EP-2735451-B1 | Polymer blend and article of manufacture such as a tire comprising such a blend | GOODYEAR TIRE & RUBBER (US) | 2015-11-04 | — | — | EP | claimed |
| EP-0826751-B1 | Aqueous dispersions containing graft copolymers as the dispersant | DU PONT (US) | 2004-04-28 | — | — | EP | claimed |
| EP-0851014-B1 | Ink jet inks containing hydrosols as polymer additives | DU PONT (US) | 2002-07-03 | — | — | EP | claimed |
| EP-0779305-B1 | Macromonomers with high acid content and their method of preparation | DU PONT (US) | 1999-03-03 | — | — | EP | claimed |
| EP-3311994-B2 | 3D PRINTING METHOD FOR THE PRODUCTION OF A SPECTACLE LENS | ZEISS CARL VISION INT GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12446802-B2 | Diffusion layer for an enzymatic in-vivo sensor | ROCHE DIABETES CARE, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20240189861-A1 | MULTILAYER BARRIER FILM, ITS MANUFACTURE AND USE IN PHOTOVOLTAIC APPLICATIONS | BASF COATINGS GMBH (DE) | 2024-06-13 | — | — | US | disclosed |
| US-20050037281-A1 | Light-sensitive sheet comprising support, first and second light-sensitive layers and barrier layer | FUJI PHOTO FILM CO., LTD. | 2005-02-17 | — | — | US | disclosed |
| US-6340562-B1 | HIGH SENSITIVITY, LOW FOG AND EXCELLENT PRESSURE RESISTANCE | KONICA CORPORATION (JP) | 2002-01-22 | — | — | US | disclosed |
| EP-0586974-B1 | Silver halide colour photographic material | AGFA GEVAERT AG (DE) | 1998-12-09 | — | — | EP | disclosed |
| EP-0586974-A1 | Silver halide colour photographic material | AGFA-GEVAERT AG (DE) | 1994-03-16 | — | — | EP | disclosed |
| EP-0332165-A2 | Silver halide color reversal photographic light-sensitive material | Fuji Photo Film Co., Ltd. (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | LDHA, LDHB, BTD | ALDH1A1 253/4885EPHX2 728/4885TBXAS1 2182/4885 |
| US-20210138218-A1 | ULTRASOUND-RESPONSIVE CONTAINERS FOR DRUG DELIVERY | MSN, SON, FAU | ALDH1A1 4486/4885EPHX2 4213/4885TBXAS1 3441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.